Video

ODYSSEY-Diabetes Trial: Latest Results

Conference|ADA Scientific Sessions - American Diabetes Association Scientific Sessions

Results of this trial were presented at the ADA Meeting in San Diego.

Kausik K. Ray, MB, ChB, MD, Professor of Public Health in the Department of Public Health and Primary Care at Imperial College London discusses the main takeaways from the 10 ODYSSEY trials.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!
Related Videos
OPC Pharmacy Times
Related Content
Close-up image of Semaglutide pens for glucose and weight management Image credit: Edugrafo | stock.adobe.com
June 22nd 2025

ADA 2025: CagriSema Demonstrates Significant Weight Loss in REDEFINE Clinical Trials

Kennedy Ferruggia, Assistant Editor
Pharmacy Focus: Navigating Seasonal Allergies
May 28th 2025

Pharmacy Focus: Navigating Seasonal Allergies

Luke Halpern, Assistant Editor Derek Webb, PharmD
OPC 2025: Adapting Oncology Pharmacy to the Age of AI and Drug Shortages
June 20th 2025

OPC 2025: Adapting Oncology Pharmacy to the Age of AI and Drug Shortages

Alana Hippensteele, Lead Editor
Pharmacists Can Be At the Forefront of Cardio-Kidney-Metabolic Management
May 6th 2025

Pharmacists Can Be At the Forefront of Cardio-Kidney-Metabolic Management

Aislinn Antrim, Managing Editor Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPS-AQ Cardiology, CACP
Cropped of black man receiving vaccine shot
June 20th 2025

Expanding Pneumococcal Vaccinations to Healthy Adults Aged 50 to 64 Years Offers Significant Health, Economic Benefits

Luke Halpern, Assistant Editor
FDA Approves Dupilumb for Treatment of Bullous Pemphigoid
June 20th 2025

FDA Approves Dupilumb for Treatment of Bullous Pemphigoid

Aislinn Antrim, Managing Editor